 | |
| Clinical data | |
|---|---|
| Other names | Dioxethedrine; 3,4-Dihydroxy-N-ethylnorephedrine; 3,4,β-Trihydroxy-N-ethyl-α-methyl-β-phenethylamine; 3,4,β-Trihydroxy-N-ethylamphetamine; α-Methyl-N-ethylnorepinephrine |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.007.137 |
| Chemical and physical data | |
| Formula | C11H17NO3 |
| Molar mass | 211.261 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Dioxethedrin (INNTooltip International Nonproprietary Name), ordioxethedrine, also known as3,4-dihydroxy-N-ethylnorephedrine, is asympathomimeticmedication.[1][2][3] It was a component of theantitussivesyrupBexol (acombination of dioxethedrin,codeine, andpromethazine).[4][5] It is anephedrinederivative (and hence is aphenethylamine andamphetamine) and is described as abronchodilator andβ-adrenergic receptor agonist.[2][4]Analogues of dioxethedrin includedioxifedrine (α-methylepinephrine; 3,4-dihydroxyephedrine),corbadrine (levonordefrin; α-methylnorepinephrine), andα-methyldopamine.[1]
 | Thisdrug article relating to thecardiovascular system is astub. You can help Wikipedia byadding missing information. |